Image source: Getty Images.
Seattle Genetics (NASDAQ: SGEN) might only have one drug on the market for now, but it’s making the most of it, with sales continuing to grow, and the losses continuing to grow smaller.
Image source: Getty Images.
Seattle Genetics (NASDAQ: SGEN) might only have one drug on the market for now, but it’s making the most of it, with sales continuing to grow, and the losses continuing to grow smaller.